LGBTQ, Sexual Behavior
Conditions
Keywords
on-line intervention
Brief summary
This study is to test the efficacy of an online CBT intervention (EQuIP) that addresses the pathways through which minority stress compromises LGBTQ young adults' co-occurring mental (e.g., depression) and behavioral (e.g., substance use, condomless anal sex) health problems. This purpose of this study is to determine if the treatment is efficacious when delivered online and if its efficacy exceeds that of the self-monitoring control.
Detailed description
To evaluate the preliminary efficacy of an LGBTQ-affirmative online CBT treatment and whether such an LGBTQ-affirmative focus adds benefit, a 2-arm RCT that would examine (1) whether online EQuIP demonstrates significant mental health improvements compared to self-monitoring of stress and mood, and (2) whether participant baseline LGBTQ-specific stress exposure moderates treatment efficacy, such that participants with the most LGBTQ-specific stress exposure benefit more from online EQuIP than self-monitoring of stress and mood. The primary outcomes are depressive symptoms, anxiety symptoms, substance abuse, sexual risk behavior, and suicidality, all of which disproportionally affect LGBTQ young adults. Secondary outcomes include hypothesized cognitive, affective, and behavioral minority stress mechanisms, such as internalized homophobia, rejection sensitivity, concealment, social isolation, and emotional dysregulation. Participants will be randomized to either self-monitoring control or Online EQuIP group. Self-monitoring control: In this control condition, participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey. This type of self-monitoring has been shown to yield improvement in behavioral health outcomes. Self-reporting LGBTQ stress experiences has also been shown to produce reductions in depression symptoms over time. Participants will record these experiences once per week for 10 weeks. Online EQuIP: This online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks. Modules contain weekly psychoeducational text and vignettes about minority stress and mental health; brief videos illustrating the CBT skills; and homework exercises that therapists review and provide feedback on. Homework exercises include weekly tracking of stressful situations and mood, practicing new skills (e.g., mindfulness, cognitive restructuring), and exercises related to considering the origins of stress and negative emotions that participants may be experiencing. Therapists provide feedback after each homework assignment, including reviewing each participant's treatment goals as part of the first session's homework. Therapists who support this condition will be instructed to incorporate LGBTQ-specific content and feedback into homework reviews. Therapists will either be postdoctoral fellows in the Pachankis lab or clinical/counseling psychology interns/externs in the Pachankis lab who possess an advanced degree in a mental health field with significant prior experience treating LGBTQ young adults with mental health concerns. Modules were adapted directly from the in-person materials (e.g., therapist manual, participant handouts) used in our previously successful trials of this treatment. A team of six therapists and supervisors of the original in-person treatment adapted the text for the online modules, including realistic vignettes and easy-to-follow skills training. A video production company created accompanying videos with our clinical team's close input. In preparation for this RCT, the online EQuIP treatment was delivered to 14 LGBTQ young adults who meet all eligibility criteria for the full trial. The purpose of this initial test was to ensure acceptability of the treatment content and usability of the technical platform.
Interventions
This online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.
Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks
Sponsors
Study design
Eligibility
Inclusion criteria
* identify as lesbian, bisexual, gay, or another sexual minority identity (e.g., pansexual, demisexual) * past-week symptoms of depression or anxiety using the Brief Symptom Inventory-4 cutoff of 2.5 on either the depression subscale or anxiety subscale * weekly access to internet on a laptop, desktop, or tablet device * ability to read, write, and speak in English * provision of informed consent.
Exclusion criteria
* current active suicidality or homicidality (defined as active intent or concrete plan, as opposed to passive suicidal ideation) * evidence of active untreated mania, psychosis, or gross cognitive impairment - current enrollment in an intervention study * current enrollment in intensive mental health treatment (i.e., receiving mental health treatment more than once per month or 8 or more sessions of CBT within the past year.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Distress | Baseline, 4 months, 8 months | Distress will be measured using the Brief Symptom Inventory (BSI). The BSI is an 18 item measure that uses a 0-4 rating scale for each item. An overall score of 72 would be the highest possible score on the measure and would indicate an extreme level of overall distress. |
| Change in Depression | Baseline, 4 months, 8 months | Depression will be measured using the Center for Epidemiological Studies -- Depression Scale (CESD). This 20-item measure uses a 0-3 rating (Rarely or none of the time - Most or all of the time) scale and sums across the items with items 3, 11, 14, and 16 reversed. for a minimum score of 0 and a maximum score of 60. Higher scores indicate greater severity of depression. In cases with internally missing data (items not answered), the sums are computed after imputation of the missing values: # items on scale / # actually answered, multiplied by the sum obtained from the answered items. A higher score indicates more depressive symptomatology during the past week. |
| Change in Depression Severity | Baseline, 4 months, 8 months | Depression severity will be measured using the Overall Depression Severity & Impairment Scale (ODSIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the severity of depression. |
| Change in Anxiety Symptoms | Baseline, 4 months, 8 months | Anxiety symptoms will be measured by the Overall Anxiety Severity & Impairment Scale (OASIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the presence of anxiety symptoms. |
| Number of Participants Reporting Any Alcohol Use | Baseline, 4 months, 8 months | Alcohol use in participants will be assessed using the Alcohol Use Disorders Identification (AUDIT) instrument. Any alcohol use over the past 3 months will be measured through the first item of the instrument (How often, during the last 3 months did you have a drink containing alcohol?) with the creation of a binary variable (1 = any alcohol use, 0 = no alcohol use). |
| Number of Participants Reporting Any Suicidal Ideation | Baseline, 4 months, 8 months | Suicidal ideation will be measured using the Suicidal Ideation Attributes Scale (SIDAS). Any suicidal ideation was assessed through the first item of this scale (In the past month, how often have you had thoughts about suicide?) with the creation of a binary variable (1 = any suicidal ideation, 0 = no suicidal ideation). |
| Number of Participants Reporting Any Sexual Risk Behavior | Baseline, 4 months, 8 months | Sexual risk behavior is defined as: condomless anal or vaginal/frontal sex \[not counting the sole use of prosthetics\] in the absence of PrEP, with any HIV+ partner \[except primary HIV+ partners with a known undetectable viral load\] or status-unknown partner. A binary variable of any sexual risk behavior was constructed from reports of past-90 day sexual behavior (1 = any sexual risk behavior, 0 = no sexual risk behavior). |
Countries
United States
Participant flow
Recruitment details
Recruitment started in May 2020 and ended in May 2021. Participants for this study were recruited from social media, mobile dating apps, LGBTQ community organizations, and via peer recruitment and referral.
Participants by arm
| Arm | Count |
|---|---|
| Online EQuIP The online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.
Online EQuIP: This online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks. | 60 |
| Self-Monitoring Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks
Self-monitoring control: Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks | 60 |
| Total | 120 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Dismissal due to ineligibility | 0 | 1 |
| Overall Study | Lost to Follow-up | 6 | 9 |
| Overall Study | Withdrawal by Subject | 6 | 1 |
Baseline characteristics
| Characteristic | Self-Monitoring | Online EQuIP | Total |
|---|---|---|---|
| Age, Continuous | 22.03 years STANDARD_DEVIATION 3.51 | 21.83 years STANDARD_DEVIATION 3 | 21.93 years STANDARD_DEVIATION 3.25 |
| Difficulty Meeting Basic Needs Not very hard | 33 Participants | 32 Participants | 65 Participants |
| Difficulty Meeting Basic Needs Somewhat hard | 18 Participants | 26 Participants | 44 Participants |
| Difficulty Meeting Basic Needs Very hard | 9 Participants | 2 Participants | 11 Participants |
| Education Degree 4-year college degree | 16 Participants | 16 Participants | 32 Participants |
| Education Degree Advanced graduate school degree | 1 Participants | 1 Participants | 2 Participants |
| Education Degree Associate's degree | 2 Participants | 1 Participants | 3 Participants |
| Education Degree High school diploma or GED | 9 Participants | 4 Participants | 13 Participants |
| Education Degree Less than high school | 1 Participants | 1 Participants | 2 Participants |
| Education Degree Some college | 17 Participants | 24 Participants | 41 Participants |
| Education Degree Some graduate school | 2 Participants | 4 Participants | 6 Participants |
| Education Degree Some high school | 12 Participants | 9 Participants | 21 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 11 Participants | 11 Participants | 22 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 49 Participants | 49 Participants | 98 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Financial Worry | 3.23 score on a scale STANDARD_DEVIATION 1.17 | 3.23 score on a scale STANDARD_DEVIATION 1.01 | 3.23 score on a scale STANDARD_DEVIATION 1.09 |
| Race/Ethnicity, Customized Race/ethnicity American Indian or Alaskan Native | 1 Participants | 0 Participants | 1 Participants |
| Race/Ethnicity, Customized Race/ethnicity Asian | 8 Participants | 12 Participants | 20 Participants |
| Race/Ethnicity, Customized Race/ethnicity Black/African American | 2 Participants | 1 Participants | 3 Participants |
| Race/Ethnicity, Customized Race/ethnicity Multiracial/Multiple Races | 11 Participants | 9 Participants | 20 Participants |
| Race/Ethnicity, Customized Race/ethnicity Native Hawaiian/Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race/Ethnicity, Customized Race/ethnicity Other | 1 Participants | 3 Participants | 4 Participants |
| Race/Ethnicity, Customized Race/ethnicity White, Hispanic/Latinx | 7 Participants | 6 Participants | 13 Participants |
| Race/Ethnicity, Customized Race/ethnicity White, Non-Hispanic/Latinx | 30 Participants | 29 Participants | 59 Participants |
| Sex Assigned at Birth Female | 49 Participants | 42 Participants | 91 Participants |
| Sex Assigned at Birth Intersex | 1 Participants | 1 Participants | 2 Participants |
| Sex Assigned at Birth Male | 10 Participants | 17 Participants | 27 Participants |
| Sex/Gender, Customized Gender identity Cisgender man | 5 Participants | 10 Participants | 15 Participants |
| Sex/Gender, Customized Gender identity Cisgender woman | 29 Participants | 22 Participants | 51 Participants |
| Sex/Gender, Customized Gender identity Nonbinary (e.g., genderqueer, agender, gender fluid) | 12 Participants | 17 Participants | 29 Participants |
| Sex/Gender, Customized Gender identity Other | 4 Participants | 5 Participants | 9 Participants |
| Sex/Gender, Customized Gender identity Transgender man | 8 Participants | 3 Participants | 11 Participants |
| Sex/Gender, Customized Gender identity Transgender woman | 2 Participants | 3 Participants | 5 Participants |
| Sexual Orientation Asexual | 3 Participants | 3 Participants | 6 Participants |
| Sexual Orientation Bisexual | 20 Participants | 21 Participants | 41 Participants |
| Sexual Orientation Gay | 8 Participants | 11 Participants | 19 Participants |
| Sexual Orientation Lesbian | 14 Participants | 6 Participants | 20 Participants |
| Sexual Orientation Other | 1 Participants | 4 Participants | 5 Participants |
| Sexual Orientation Pansexual | 4 Participants | 4 Participants | 8 Participants |
| Sexual Orientation Queer | 10 Participants | 11 Participants | 21 Participants |
| U.S. Region Midwest | 10 Participants | 11 Participants | 21 Participants |
| U.S. Region Northeast | 13 Participants | 9 Participants | 22 Participants |
| U.S. Region South | 25 Participants | 28 Participants | 53 Participants |
| U.S. Region West | 12 Participants | 12 Participants | 24 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 60 | 0 / 60 |
| other Total, other adverse events | 1 / 60 | 0 / 60 |
| serious Total, serious adverse events | 0 / 60 | 1 / 60 |
Outcome results
Change in Anxiety Symptoms
Anxiety symptoms will be measured by the Overall Anxiety Severity & Impairment Scale (OASIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the presence of anxiety symptoms.
Time frame: Baseline, 4 months, 8 months
Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Online EQuIP | Change in Anxiety Symptoms | Baseline | 9.12 score on a scale | Standard Error 0.39 |
| Online EQuIP | Change in Anxiety Symptoms | 4-month post-baseline | 7.32 score on a scale | Standard Error 0.53 |
| Online EQuIP | Change in Anxiety Symptoms | 8-month post-baseline | 7.25 score on a scale | Standard Error 0.52 |
| Self-Monitoring | Change in Anxiety Symptoms | Baseline | 8.97 score on a scale | Standard Error 0.44 |
| Self-Monitoring | Change in Anxiety Symptoms | 4-month post-baseline | 7.45 score on a scale | Standard Error 0.51 |
| Self-Monitoring | Change in Anxiety Symptoms | 8-month post-baseline | 7.52 score on a scale | Standard Error 0.6 |
Change in Depression
Depression will be measured using the Center for Epidemiological Studies -- Depression Scale (CESD). This 20-item measure uses a 0-3 rating (Rarely or none of the time - Most or all of the time) scale and sums across the items with items 3, 11, 14, and 16 reversed. for a minimum score of 0 and a maximum score of 60. Higher scores indicate greater severity of depression. In cases with internally missing data (items not answered), the sums are computed after imputation of the missing values: # items on scale / # actually answered, multiplied by the sum obtained from the answered items. A higher score indicates more depressive symptomatology during the past week.
Time frame: Baseline, 4 months, 8 months
Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Online EQuIP | Change in Depression | Baseline | 14.17 score on a scale | Standard Error 0.36 |
| Online EQuIP | Change in Depression | 4-month post-baseline | 12.68 score on a scale | Standard Error 0.57 |
| Online EQuIP | Change in Depression | 8-month post-baseline | 12.44 score on a scale | Standard Error 0.48 |
| Self-Monitoring | Change in Depression | Baseline | 15.41 score on a scale | Standard Error 0.47 |
| Self-Monitoring | Change in Depression | 4-month post-baseline | 13.45 score on a scale | Standard Error 0.5 |
| Self-Monitoring | Change in Depression | 8-month post-baseline | 13.38 score on a scale | Standard Error 0.5 |
Change in Depression Severity
Depression severity will be measured using the Overall Depression Severity & Impairment Scale (ODSIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the severity of depression.
Time frame: Baseline, 4 months, 8 months
Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Online EQuIP | Change in Depression Severity | Baseline | 7.20 score on a scale | Standard Error 0.54 |
| Online EQuIP | Change in Depression Severity | 4-month post-baseline | 6.07 score on a scale | Standard Error 0.73 |
| Online EQuIP | Change in Depression Severity | 8-month post-baseline | 6.15 score on a scale | Standard Error 0.74 |
| Self-Monitoring | Change in Depression Severity | Baseline | 8.40 score on a scale | Standard Error 0.58 |
| Self-Monitoring | Change in Depression Severity | 4-month post-baseline | 6.98 score on a scale | Standard Error 0.58 |
| Self-Monitoring | Change in Depression Severity | 8-month post-baseline | 6.63 score on a scale | Standard Error 0.73 |
Change in Distress
Distress will be measured using the Brief Symptom Inventory (BSI). The BSI is an 18 item measure that uses a 0-4 rating scale for each item. An overall score of 72 would be the highest possible score on the measure and would indicate an extreme level of overall distress.
Time frame: Baseline, 4 months, 8 months
Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Online EQuIP | Change in Distress | Baseline | 1.43 score on a scale | Standard Error 0.07 |
| Online EQuIP | Change in Distress | 4-month Post-baseline | 1.22 score on a scale | Standard Error 0.11 |
| Online EQuIP | Change in Distress | 8-month Post-baseline | 1.07 score on a scale | Standard Error 0.1 |
| Self-Monitoring | Change in Distress | Baseline | 1.57 score on a scale | Standard Error 0.09 |
| Self-Monitoring | Change in Distress | 4-month Post-baseline | 1.34 score on a scale | Standard Error 0.11 |
| Self-Monitoring | Change in Distress | 8-month Post-baseline | 1.21 score on a scale | Standard Error 0.09 |
Number of Participants Reporting Any Alcohol Use
Alcohol use in participants will be assessed using the Alcohol Use Disorders Identification (AUDIT) instrument. Any alcohol use over the past 3 months will be measured through the first item of the instrument (How often, during the last 3 months did you have a drink containing alcohol?) with the creation of a binary variable (1 = any alcohol use, 0 = no alcohol use).
Time frame: Baseline, 4 months, 8 months
Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Online EQuIP | Number of Participants Reporting Any Alcohol Use | Baseline | 42 Participants |
| Online EQuIP | Number of Participants Reporting Any Alcohol Use | 4-month post-baseline | 28 Participants |
| Online EQuIP | Number of Participants Reporting Any Alcohol Use | 8-month post-baseline | 34 Participants |
| Self-Monitoring | Number of Participants Reporting Any Alcohol Use | Baseline | 41 Participants |
| Self-Monitoring | Number of Participants Reporting Any Alcohol Use | 4-month post-baseline | 36 Participants |
| Self-Monitoring | Number of Participants Reporting Any Alcohol Use | 8-month post-baseline | 34 Participants |
Number of Participants Reporting Any Sexual Risk Behavior
Sexual risk behavior is defined as: condomless anal or vaginal/frontal sex \[not counting the sole use of prosthetics\] in the absence of PrEP, with any HIV+ partner \[except primary HIV+ partners with a known undetectable viral load\] or status-unknown partner. A binary variable of any sexual risk behavior was constructed from reports of past-90 day sexual behavior (1 = any sexual risk behavior, 0 = no sexual risk behavior).
Time frame: Baseline, 4 months, 8 months
Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Online EQuIP | Number of Participants Reporting Any Sexual Risk Behavior | Baseline | 4 Participants |
| Online EQuIP | Number of Participants Reporting Any Sexual Risk Behavior | 4-month post-baseline | 2 Participants |
| Online EQuIP | Number of Participants Reporting Any Sexual Risk Behavior | 8-month post-baseline | 4 Participants |
| Self-Monitoring | Number of Participants Reporting Any Sexual Risk Behavior | Baseline | 3 Participants |
| Self-Monitoring | Number of Participants Reporting Any Sexual Risk Behavior | 4-month post-baseline | 4 Participants |
| Self-Monitoring | Number of Participants Reporting Any Sexual Risk Behavior | 8-month post-baseline | 3 Participants |
Number of Participants Reporting Any Suicidal Ideation
Suicidal ideation will be measured using the Suicidal Ideation Attributes Scale (SIDAS). Any suicidal ideation was assessed through the first item of this scale (In the past month, how often have you had thoughts about suicide?) with the creation of a binary variable (1 = any suicidal ideation, 0 = no suicidal ideation).
Time frame: Baseline, 4 months, 8 months
Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Online EQuIP | Number of Participants Reporting Any Suicidal Ideation | Baseline | 37 Participants |
| Online EQuIP | Number of Participants Reporting Any Suicidal Ideation | 4-month post-baseline | 25 Participants |
| Online EQuIP | Number of Participants Reporting Any Suicidal Ideation | 8-month post-baseline | 28 Participants |
| Self-Monitoring | Number of Participants Reporting Any Suicidal Ideation | Baseline | 35 Participants |
| Self-Monitoring | Number of Participants Reporting Any Suicidal Ideation | 4-month post-baseline | 24 Participants |
| Self-Monitoring | Number of Participants Reporting Any Suicidal Ideation | 8-month post-baseline | 25 Participants |